130 related articles for article (PubMed ID: 37436385)
21. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
Cytometry B Clin Cytom; 2014 Mar; ():. PubMed ID: 24659135
[TBL] [Abstract][Full Text] [Related]
22. [Effective measurement of coronary flow velocity reserve (CFVR) with transthoracic Doppler echocardiography (TTDE) for plasma cell leukemia with hyperviscosity syndrome].
Oka S; Yokote T; Akioka T; Hara S; Yamano T; Okabe T; Arishiro K; Hoshiga M; Shimizu A; Tsuji M; Hanafusa T
Rinsho Ketsueki; 2006 Jan; 47(1):16-22. PubMed ID: 16479978
[TBL] [Abstract][Full Text] [Related]
23. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
Gangadhar P; Ahmed Z; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and laboratory features of four cases with IgM multiple myeloma].
Fan JL; Fu WJ; Shi HT; Zhou F; Yuan ZG; Zhang CY; Wei W; Ye F; Zhang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):341-4. PubMed ID: 23668209
[TBL] [Abstract][Full Text] [Related]
25. Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient.
Langer S; Mehta M; Saraf A; Gupta A; Pipliya K; Kakar A; Bhargava M
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):173-7. PubMed ID: 27408384
[TBL] [Abstract][Full Text] [Related]
26. cCD79a expression in a case of plasma cell leukemia.
Alonso ML; Rubiol E; Mateu R; Estivill C; Bellido M; Balmaña J; Nomdedéu JF
Leuk Res; 1998 Jul; 22(7):649-53. PubMed ID: 9680117
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients.
Awasthi NP; Mishra S; Gupta G; Kumari S; Bajpayee A; Singh P; Husain N
Indian J Pathol Microbiol; 2023; 66(2):295-300. PubMed ID: 37077071
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
[TBL] [Abstract][Full Text] [Related]
29. Oligosecretory Primary Plasma Cell Leukemia with Atypical Morphological Abnormality.
Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
[TBL] [Abstract][Full Text] [Related]
30. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
31. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
32. A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein. Immunohistochemical and molecular analysis.
Tanioka F; Tamashima S; Shimizu S; Kobayashi H; Kobayashi Y; Sugimura H
Jpn J Clin Oncol; 2003 May; 33(5):232-7. PubMed ID: 12865467
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
34. The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: a new statistical model.
Cannizzo E; Carulli G; Del Vecchio L; Ottaviano V; Bellio E; Zenari E; Azzarà A; Petrini M; Preffer F
Am J Clin Pathol; 2012 Mar; 137(3):377-86. PubMed ID: 22338049
[TBL] [Abstract][Full Text] [Related]
35. Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells.
Meyerson HJ; Bailey J; Miedler J; Olobatuyi F
Cytometry B Clin Cytom; 2011 Mar; 80(2):71-82. PubMed ID: 21337490
[TBL] [Abstract][Full Text] [Related]
36. [Comparison and analysis of minimal residual disease in multiple myeloma patients detected by 4-color and 8-color fluorescence antibody panels].
Wang YZ; Lu J; Hao L; Chang Y; He LL; Huang XJ; Liu YR
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):272-278. PubMed ID: 28468086
[No Abstract] [Full Text] [Related]
37. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
Jeong TD; Park CJ; Shim H; Jang S; Chi HS; Yoon DH; Kim DY; Lee JH; Lee JH; Suh C; Lee KH
Korean J Hematol; 2012 Dec; 47(4):260-6. PubMed ID: 23320004
[TBL] [Abstract][Full Text] [Related]
38. Plasma cell leukemia - one in a million: A case report.
Jain AG; Faisal-Uddin M; Khan AK; Wazir M; Shen Q; Manoucheri M
World J Clin Oncol; 2019 Mar; 10(3):161-165. PubMed ID: 30949445
[TBL] [Abstract][Full Text] [Related]
39. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
40. [Immunoglobulin M multiple myeloma: a six-case report and literature review].
Yan WW; Fan HS; Xu JY; Liu JH; Du CX; Deng SH; Sui WW; Xu Y; Qiu LG; An G
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1011-1014. PubMed ID: 35045672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]